证券记录 · 已归档季度
STAA
STAAR Surgical Company · Healthcare · Medical - Instruments & Supplies
11被追踪持有人
+1Δ持有人
5.51M持有股份
$204.79M报告持仓市值
+2新建仓位
−1清仓
动量输入（同类管理人）：
持有人广度 +10.0% ·
股份流向 -1.7% ·
净新建仓位 +9.1%
— 公式
持股分散化 — 持有人增多，合计持仓比例缩小
所有持股数据：仅限已追踪的 13F 管理人，普通股持仓，报告期 Q3 2024
持股变化趋势
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q2 2026 | 75 | +6 | 22.78M | $653.08M | +13 | −6 |
| Q1 2026 | 71 | -2 | 21.75M | $407.04M | +10 | −12 |
| Q4 2025 | 73 | +2 | 25.59M | $590.84M | +2 | — |
| Q3 2025 | 16 | +2 | 16.83M | $452.11M | +3 | −1 |
| Q2 2025 | 11 | 0 | 16.25M | $272.61M | — | — |
| Q1 2025 | 8 | -2 | 3.84M | $67.78M | +1 | −3 |
| Q4 2024 | 10 | -2 | 5.93M | $144.12M | +1 | −3 |
| Q3 2024 | 11 | +1 | 5.51M | $204.79M | +2 | −1 |
| Q2 2024 | 10 | — | 5.61M | $267.04M | — | — |
持有人 · Q3 2024
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Baillie Gifford ✦ | 1.46M | -60.3% | $54.26M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 2 | Baillie Gifford ✦ | 1.46M | -60.3% | $54.26M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 3 | Baillie Gifford ✦ | 1.46M | -60.3% | $54.26M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 4 | Baillie Gifford ✦ | 1.46M | -60.3% | $54.26M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 5 | Geode Capital Management ✦ (被动) | 1.17M | +2.7% | $43.64M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 6 | Geode Capital Management ✦ (被动) | 1.17M | +2.7% | $43.64M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 7 | Citadel Advisors ✦ | 934.33K | +538.1% | $34.71M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 8 | Citadel Advisors ✦ | 934.33K | +538.1% | $34.71M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 9 | Millennium Management ✦ | 842.22K | +371.1% | $31.29M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 10 | Marshall Wace ✦ | 344.58K | +91.8% | $12.80M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 11 | Marshall Wace ✦ | 344.58K | +91.8% | $12.80M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 12 | Renaissance Technologies ✦ | 303.90K | +344.3% | $11.29M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 13 | Norges Bank ✦ (被动) | 272.44K | 新增 | $10.12M | 0.0% | New | 1 | SEC ↗ |
| 14 | AQR Capital Management ✦ | 90.71K | 新增 | $3.37M | 0.0% | New | 1 | SEC ↗ |
| 15 | AQR Capital Management ✦ | 90.71K | 新增 | $3.37M | 0.0% | New | 1 | SEC ↗ |
| 16 | AQR Capital Management ✦ | 90.71K | 新增 | $3.37M | 0.0% | New | 1 | SEC ↗ |
| 17 | Two Sigma Investments ✦ | 37.40K | +149.9% | $1.39M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 18 | T. Rowe Price ✦ | 32.55K | +1.3% | $1.21M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 19 | Bridgewater Associates ✦ | 19.28K | -51.6% | $716,289 | 0.0% | ▼ Trim | 2 | SEC ↗ |
"持仓权重"= 该持仓占该管理人已申报13F股权价值的比例——即信念度衡量指标。✦ = 精选管理人。
新增买入方
| Norges Bank | $10.12M | 0.0% |
| AQR Capital Management | $3.37M | 0.0% |
| AQR Capital Management | $3.37M | 0.0% |
| AQR Capital Management | $3.37M | 0.0% |
已清仓
| D. E. Shaw & Co. | $5.84M | 曾为 0.0% |
全市场背景: 涵盖所有13F申报机构（SEC结构化数据， Q1 2026): 186 持有人, 53.87M 股份, $998.22M 已申报. 这是与上方被追踪全域数据不同的较早期间，两者从不混用。
常见共同持仓
该证券的被追踪持有人最常同时持有的其他证券——基于共同持有计数，而非基本面关联。
Aug 14
SC 13G/A — Madison Avenue Partners, LP
数据来源: 持股数据来源于已解析的13F普通股持仓（被追踪范围，变动对比集）；内部人行为来自Form 3/4/5；重大持股来自Schedule 13D/13G；所有文件均链接至SEC EDGAR原始申报。
报告期: Q3 2024 ·
方法论 ·
通过API获取此数据